Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease
Author(s) -
Carsten Gnewuch,
Gerhard Liebisch,
Thomas Langmann,
Benjamin Dieplinger,
Nicolas J. Mueller,
Meinhard Haltmayer,
Hans Dieplinger,
Alexandra Zahn,
Wolfgang Stremmel,
Gerhard Rogler,
Gerd Schmitz
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.3134
Subject(s) - tauroursodeoxycholic acid , fgf19 , glycocholic acid , ursodeoxycholic acid , chenodeoxycholic acid , bile acid , gastroenterology , medicine , ulcerative colitis , cholic acid , deoxycholic acid , inflammatory bowel disease , lithocholic acid , primary sclerosing cholangitis , taurocholic acid , enterohepatic circulation , bile acid malabsorption , chemistry , disease , biochemistry , receptor , endoplasmic reticulum , unfolded protein response , fibroblast growth factor
To determine free and conjugated serum bile acid (BA) levels in inflammatory bowel disease (IBD) subgroups with defined clinical manifestations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom